Displaying 2801 - 2820 of 4737
FTC Puts Conditions on Actavis plc’s Acquisition of Forest Laboratories, Inc.
Motorola Mobility LLC v. AU Optronics Corp.
1406018 Informal Interpretation
1406010 Informal Interpretation
1406012 Informal Interpretation
FTC Approves Final Order Settling Charges That Akorn Enterprises’ Acquisition of Hi-Tech Pharmacal Was Anticompetitive
Akorn and Hi-Tech Pharmacal, In the Matter of
Akorn Enterprises, Inc. and Hi-Tech Pharmacal, Inc. agreed to sell the rights and assets to three generic prescription eye medications and two generic topical anesthetics to Watson Laboratories, Inc., to settle FTC charges that Akorn’s proposed $640 million acquisition of Hi-Tech would be anticompetitive and lead to higher prices for consumers. The proposed order requires the parties to sell either Akorn’s or Hi-Tech’s rights and assets to each of the five drug products to Watson, and requires Akorn to assign Watson its contract for making branded and generic EMLA cream within 10 days after the deal is consummated. In addition, the companies must maintain the drugs to be sold as viable, marketable, and competitive pending their divestiture, and must allow the FTC to appoint a monitor to ensure that the companies comply with the order’s requirements.
1406009 Informal Interpretation
FTC Amicus Brief: Improper Use of Restricted Drug Distribution Programs May Impede Generic Competition
FTC Approves Final Order Settling Charges That Ardagh’s Proposed Acquisition of Saint-Gobain Would Be Anticompetitive; Approves Ardagh’s Application to Sell Six Glass Plants and Related Assets
FTC Requests Public Comments on SCI’s Application to Approve Sale of Cemetery Assets in Maryland to Parkwood Memorial Association, Inc.
Ardagh Group S.A., Saint-Gobain Containers, Inc., and Compagnie de Saint-Gobain, In the Matter of
The FTC challenged Ardagh Group, S.A.’s proposed $1.7 billion acquisition of Saint-Gobain Containers, Inc., alleging that it will reduce competition and result in the two firms – the merged firm and its only remaining significant competitor, Owens-Illinois – controlling in excess of 75 percent of the U.S. markets for glass containers for beer and spirits customers, resulting in higher prices for those customers. The FTC issued an administrative complaint against the two companies, alleging that the acquisition would violate U.S. antitrust law. The proposed acquisition would combine the second-largest manufacturer of glass containers (Saint-Gobain) and the third-largest (Ardagh).The complaint alleges that glass container competitors possess a wealth of information about each other and the glass container industry, and that reducing the number of major competitors from three to two will make it substantially easier for the remaining two competitors to coordinate with one another to achieve supracompetitive prices or other anticompetitive outcomes. The Commission also filed a motion for a preliminary injunction in federal court to preserve the status quo pending the outcome of the administrative trial on the merits. On 11/3/13, the parties stipulated to a hold separate order in the federal court proceeding. On 11/8/13 the Commission stayed the part 3 litigation pending settlement discussions. On 4/10/14, Ardagh Group SA agreed to sell six of its nine glass container manufacturing plants in the United States to settle the FTC's charges. The FTC’s settlement order requires Ardagh to sell six of the manufacturing plants and related assets it acquired through its 2012 acquisition of Anchor Glass Container Corporation, along with Anchor’s former corporate headquarters in Tampa, Fla.
Mylan Pharmaceuticals, Inc. v. Celgene Corporation
1406008 Informal Interpretation
1406007 Informal Interpretation
1406006 Informal Interpretation
The Impact of Outages on Prices and Investment in the US Oil Refining Industry
Displaying 2801 - 2820 of 4737